164 related articles for article (PubMed ID: 8806958)
1. Differential sensitivity of estrogen/progesterone receptors and BRST-2 markers in metastatic ductal and lobular breast carcinoma to the skin.
Wallace ML; Smoller BR
Am J Dermatopathol; 1996 Jun; 18(3):241-7. PubMed ID: 8806958
[TBL] [Abstract][Full Text] [Related]
2. Estrogen and progesterone receptors in breast cancer.
Couch P
Am J Dermatopathol; 1997 Oct; 19(5):553-5. PubMed ID: 9335253
[No Abstract] [Full Text] [Related]
3. Estrogen and progesterone receptors and anti-gross cystic disease fluid protein 15 (BRST-2) fail to distinguish metastatic breast carcinoma from eccrine neoplasms.
Wallace ML; Longacre TA; Smoller BR
Mod Pathol; 1995 Dec; 8(9):897-901. PubMed ID: 8751328
[TBL] [Abstract][Full Text] [Related]
4. Immunohistochemical analysis of pleomorphic lobular carcinoma: higher expression of p53 and chromogranin and lower expression of ER and PgR.
Radhi JM
Histopathology; 2000 Feb; 36(2):156-60. PubMed ID: 10672061
[TBL] [Abstract][Full Text] [Related]
5. Homologous carcinomas of the breasts, skin, and salivary glands. A histologic and immunohistochemical comparison of ductal mammary carcinoma, ductal sweat gland carcinoma, and salivary duct carcinoma.
Wick MR; Ockner DM; Mills SE; Ritter JH; Swanson PE
Am J Clin Pathol; 1998 Jan; 109(1):75-84. PubMed ID: 9426521
[TBL] [Abstract][Full Text] [Related]
6. [Breast carcinoma metastatic to meningioma: review of the literature and description of 2 new cases].
Fornelli A; Bacci A; Collina G; Eusebi V
Pathologica; 1995 Oct; 87(5):506-12. PubMed ID: 8868176
[TBL] [Abstract][Full Text] [Related]
7. Signet ring variant of lobular carcinoma of the breast: a clinicopathologic and immunohistochemical study.
Raju U; Ma CK; Shaw A
Mod Pathol; 1993 Sep; 6(5):516-20. PubMed ID: 8248106
[TBL] [Abstract][Full Text] [Related]
8. Pleomorphic lobular carcinoma of the breast: clinicopathologic features of 12 cases.
Bentz JS; Yassa N; Clayton F
Mod Pathol; 1998 Sep; 11(9):814-22. PubMed ID: 9758360
[TBL] [Abstract][Full Text] [Related]
9. Metastatic patterns of invasive lobular versus invasive ductal carcinoma of the breast.
Borst MJ; Ingold JA
Surgery; 1993 Oct; 114(4):637-41; discussion 641-2. PubMed ID: 8211676
[TBL] [Abstract][Full Text] [Related]
10. Mucinous carcinoma of the eyelid. An immunohistochemical study.
Carson HJ; Gattuso P; Raslan WF; Reddy V
Am J Dermatopathol; 1995 Oct; 17(5):494-8. PubMed ID: 8599456
[TBL] [Abstract][Full Text] [Related]
11. Diagnostic immunohistochemistry of cutaneous metastatic breast carcinoma: a statistical analysis of the utility of gross cystic disease fluid protein-15 and estrogen receptor protein.
Ormsby AH; Snow JL; Su WP; Goellner JR
J Am Acad Dermatol; 1995 May; 32(5 Pt 1):711-6. PubMed ID: 7722013
[TBL] [Abstract][Full Text] [Related]
12. A comparison of cell cycle markers in well-differentiated lobular and ductal carcinomas.
Soslow RA; Carlson DL; Horenstein MG; Osborne MP
Breast Cancer Res Treat; 2000 May; 61(2):161-70. PubMed ID: 10942102
[TBL] [Abstract][Full Text] [Related]
13. Value of GCDFP-15 (BRST-2) as a specific immunocytochemical marker for breast carcinoma in cytologic specimens.
Fiel MI; Cernaianu G; Burstein DE; Batheja N
Acta Cytol; 1996; 40(4):637-41. PubMed ID: 8693878
[TBL] [Abstract][Full Text] [Related]
14. Histiocytoid breast carcinoma: histological, immunohistochemical, ultrastructural, cytological and clinicopathological studies.
Shimizu S; Kitamura H; Ito T; Nakamura T; Fujisawa J; Matsukawa H
Pathol Int; 1998 Jul; 48(7):549-56. PubMed ID: 9701019
[TBL] [Abstract][Full Text] [Related]
15. Endocrine organ metastases in subjects with lobular carcinoma of the breast.
Bumpers HL; Hassett JM; Penetrante RB; Hoover EL; Holyoke ED
Arch Surg; 1993 Dec; 128(12):1344-7. PubMed ID: 8250706
[TBL] [Abstract][Full Text] [Related]
16. Immunohistochemical analysis of GCDFP-15 and GCDFP-24 in mammary and non-mammary tissue.
Satoh F; Umemura S; Osamura RY
Breast Cancer; 2000 Jan; 7(1):49-55. PubMed ID: 11029771
[TBL] [Abstract][Full Text] [Related]
17. Prognostic relevance of carcinoembryonic antigen and estrogen receptor status in breast cancer patients.
Esteban JM; Felder B; Ahn C; Simpson JF; Battifora H; Shively JE
Cancer; 1994 Sep; 74(5):1575-83. PubMed ID: 7914825
[TBL] [Abstract][Full Text] [Related]
18. Androgen receptors: a marker to increase sensitivity for identifying breast cancer in skin metastasis of unknown primary site.
Bayer-Garner IB; Smoller B
Mod Pathol; 2000 Feb; 13(2):119-22. PubMed ID: 10697267
[TBL] [Abstract][Full Text] [Related]
19. High sensitivity and specificity of immunohistochemistry for the detection of hormone receptors in breast carcinoma: comparison with biochemical determination in a prospective study of 793 cases.
Zafrani B; Aubriot MH; Mouret E; De Crémoux P; De Rycke Y; Nicolas A; Boudou E; Vincent-Salomon A; Magdelénat H; Sastre-Garau X
Histopathology; 2000 Dec; 37(6):536-45. PubMed ID: 11122436
[TBL] [Abstract][Full Text] [Related]
20. Immunohistochemical differentiation between primary adenocarcinomas of the ovary and ovarian metastases of colonic and breast origin. Comparison between a statistical and an intuitive approach.
Lagendijk JH; Mullink H; van Diest PJ; Meijer GA; Meijer CJ
J Clin Pathol; 1999 Apr; 52(4):283-90. PubMed ID: 10474521
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
